Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-178.76	-215.09	-77.16
Graham Fair Price	-4.52	14.71	15.41
PEG	1548.67	-2.42	0.15
Price/Book	-22.56	3.68	4.75
Price/Cash Flow	21.54	-5.26	-6.71
Prices/Earnings	33.10	-6.32	-9.44
Price/Sales	-28.51	18.75	26.22
Price/FCF	21.54	-5.26	-6.71
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-17.08	0.11	0.13
Operating Margin	29.16	-0.43	-0.61
ROA	2.53	-0.02	-0.02
ROE	-0.13	-0.15	-15.74
ROIC	-0.02	-0.01	35.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.12	< 0.005	7457.29
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.33	0.32	-3.66
EPS QOQ	0.64	-0.03	-95.94
FCF QOQ	-0.38	0.12	-67.68
Revenue QOQ	0.06	-0.04	-33.69
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	198.19	222.91	12.47
Days Sales Outstanding (DSO)	131.20	102.47	-21.90
Inventory Turnover	0.45	0.40	-11.09
Debt/Capitalization	0.82	0.85	3.55
Quick Ratio	4.38	3.82	-12.70
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	9.16	8.13	-11.25
Cash	20.98	20.27	-3.39
Capex	-4.87	-4.60	5.64
Free Cash Flow	-6.49	-5.68	12.41
Revenue	1.66	1.60	-3.87
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	5.13	4.58	-10.76
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-33.86	-118.87	-251.10
Naive Interpretation	Member

06 - Financial Health · Bad

Rating